First Things First

Clinical genome sequencing should start as way to diagnose patients, rather than as a broad screening tool, says a group of UK researchers in the British Medical Journal.

The UK's National Health Service is taking on a project to sequence some 100,000 patients' genomes, which the researchers led by Caroline Wright at the Wellcome Trust Sanger Institute say underlines the need for a "clear testing policy."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.